top of page
![](https://static.wixstatic.com/media/11062b_61dbd21e9e0041c4b08c1b7fdee0c36f~mv2_d_6000_4000_s_4_2.jpg/v1/fill/w_1920,h_1280,al_c,q_90,usm_0.66_1.00_0.01,enc_auto/11062b_61dbd21e9e0041c4b08c1b7fdee0c36f~mv2_d_6000_4000_s_4_2.jpg)
Over-Medication and Older Adults with Intellectual Disability: Risks for Brain Health (Statement)
NTG Statement
This document, released on February 21, 2023, was issued jointly by the NTG and the Health Matters Program as part of an advisory series on risk reduction in adults with intellectual disability and promoting healthy brain outcomes. The advisory recognizes that in some instances overmedicating can have negative effects on physical and brain health, as well as potentially increase the risk for mild cognitive impairment or dementia. The intent of the advisory is that the information provided will lead to constructive scrutiny of medication use, avoid “medication harm’, and result in positive health outcomes.
bottom of page